Publicaciones (20) Publicaciones en las que ha participado algún/a investigador/a

2002

  1. 6 The Role of extreme phenotype selection in cancer research

    Handbook of Immunohistochemistry and in Situ Hybridization of Human Carcinomas, Vol. 2, pp. 65-71

  2. Ano-rectal sphincter preservation following preoperative chemoradiation in cT3-4Nx rectal cancer: Influence of tumor distance and downstaging

    Clinical and Translational Oncology, Vol. 4, Núm. 3, pp. 146-153

  3. Bloqueo subaracnoideo continuo para cirugía de abdomen inferior en un paciente de alto riesgo.

    Revista espanola de anestesiologia y reanimacion

  4. Combined irinotecan, oxaliplatin and 5-fluorouracil in patients with advanced colorectal cancer: A feasibility pilot study

    Oncology, Vol. 63, Núm. 3, pp. 254-265

  5. Comparison of unidimensional and bidimensional measurements in metastatic non-small cell lung cancer

    British Journal of Cancer, Vol. 87, Núm. 2, pp. 158-160

  6. Docetaxel plus vinorelbine as salvage chemotherapy in advanced breast cancer: A phase II study

    Breast Cancer Research and Treatment, Vol. 76, Núm. 1, pp. 47-56

  7. Docetaxel y gemcitabina en el tratamiento del carcinoma de páncreas metastásico

    Clinical and Translational Oncology, Vol. 4, Núm. 2, pp. 72-76

  8. Erratum: Multiple cycles of dose-intensive chemotherapy with repeated stem cell support as induction treatment in metastatic breast cancer: A feasibility study (Bone Marrow Transplantation (2001) vol. 28 (235-242))

    Bone Marrow Transplantation

  9. Erratum: Multiple cycles of dose-intensive chemotherapy with repeated stem cell support as induction treatment in metastatic breast cancer: a feasibility study (Bone Marrow Transplantation, (2001), 28, 3, (235-242), 10.1038/sj.bmt.1703125)

    Bone Marrow Transplantation

  10. Estudio fase II de doxorubicina liposomal pegilada (Caelyx®) en carcinoma de ovario avanzado: Analisis de eficacia y toxicidad

    Oncologia, Vol. 25, Núm. 10, pp. 42-49

  11. Gastric cancer: Multidisciplinary treatment. Changes and challenges

    Clinical and Translational Oncology

  12. Ifosfamide and vinorelbine in advanced platinum-resistant ovarian cancer: Excessive toxicity with a potentially active regimen

    Gynecologic Oncology, Vol. 84, Núm. 3, pp. 368-373

  13. Induction chemotherapy with paclitaxel, cisplatin and 5-fluorouracil for squamous cell carcinoma of the head and neck: Long-term results of a phase II trial

    Annals of Oncology, Vol. 13, Núm. 10, pp. 1665-1673

  14. Intraoperative presacral electron boost following preoperative chemoradiation in T3-4Nx rectal cancer: Initial local effects and clinical outcome analysis

    Radiotherapy and Oncology

  15. Irinotecan, oxaliplatin, and 5-fluorouracil/leucovorin combination chemotherapy in advanced colorectal carcinoma: A phase II study

    Clinical Colorectal Cancer, Vol. 2, Núm. 2, pp. 104-110

  16. Phase II study of gemcitabine and cisplatin in chemonaive patients with advanced epithelial ovarian cancer

    Anti-Cancer Drugs, Vol. 13, Núm. 8, pp. 839-845

  17. Radiation therapy after high-dose chemotherapy with peripheral blood stem cell support for high-risk breast cancer

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 25, Núm. 4, pp. 347-353

  18. Second-line chemotherapy with irinotecan and vinorelbine in stage IIIb and IV non-small-cell lung cancer: A phase II study

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 25, Núm. 5, pp. 480-484

  19. Tamoxifen therapy for ovarian cancer in the adjuvant and advanced settings: Systematic review of the literature and implications for future research

    Gynecologic Oncology, Vol. 84, Núm. 2, pp. 201-209

  20. The role of extreme phenotype selection studies in the identification of clinically relevant genotypes in cancer research

    Cancer, Vol. 95, Núm. 7, pp. 1605-1610